Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THX-110 for Obstructive Sleep Apnea
NCT03646552Phase 2Unknown
- Sponsor
- SciSparc
- Start
- Jun 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dronabinol and palmitoylethanolamide in obstructive sleep apnea (OSA), sponsored by SciSparc. Primary endpoint: Apnea-Hypopnea Index at 30 days. Status: unknown.
02
Drugs
dronabinolpalmitoylethanolamide
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03646552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03646552.